Literature DB >> 20089137

Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Emma Perez-Costas1, Miguel Melendez-Ferro, Rosalinda C Roberts.   

Abstract

Schizophrenia is a severe mental illness that affects 1% of the world population. The disease usually manifests itself in early adulthood with hallucinations, delusions, cognitive and emotional disturbances and disorganized thought and behavior. Dopamine was the first neurotransmitter to be implicated in the disease, and though no longer the only suspect in schizophrenia pathophysiology, it obviously plays an important role. The basal ganglia are the site of most of the dopamine neurons in the brain and the target of anti-psychotic drugs. In this review, we will start with an overview of basal ganglia anatomy emphasizing dopamine circuitry. Then, we will review the major deficits in dopamine function in schizophrenia, emphasizing the role of excessive dopamine in the basal ganglia and the link to psychosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089137      PMCID: PMC2929831          DOI: 10.1111/j.1471-4159.2010.06604.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  228 in total

1.  Chemical heterogeneity of the striosomal compartment in the human striatum.

Authors:  L Prensa; J M Giménez-Amaya; A Parent
Journal:  J Comp Neurol       Date:  1999-11-01       Impact factor: 3.215

Review 2.  Search for schizophrenia susceptibility genes.

Authors:  A E Pulver
Journal:  Biol Psychiatry       Date:  2000-02-01       Impact factor: 13.382

3.  A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder.

Authors:  Lynn E DeLisi; Sarah H Shaw; Timothy J Crow; Gail Shields; Angela B Smith; Veronica W Larach; Nigel Wellman; Josephine Loftus; Betsy Nanthakumar; Kamran Razi; John Stewart; Margherita Comazzi; Antonio Vita; Thomas Heffner; Robin Sherrington
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

4.  Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining.

Authors:  A M Graybiel; C W Ragsdale
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

Review 5.  The structural basis for mapping behavior onto the ventral striatum and its subdivisions.

Authors:  Gloria E Meredith; Brian A Baldo; Matthew E Andrezjewski; Ann E Kelley
Journal:  Brain Struct Funct       Date:  2008-02-07       Impact factor: 3.270

Review 6.  Molecular biology of the dopamine receptors.

Authors:  O Civelli; J R Bunzow; D K Grandy; Q Y Zhou; H H Van Tol
Journal:  Eur J Pharmacol       Date:  1991-08-14       Impact factor: 4.432

7.  Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.

Authors:  M Toru; S Watanabe; H Shibuya; T Nishikawa; K Noda; H Mitsushio; H Ichikawa; A Kurumaji; M Takashima; N Mataga
Journal:  Acta Psychiatr Scand       Date:  1988-08       Impact factor: 6.392

8.  The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination.

Authors:  C R Gerfen
Journal:  Science       Date:  1989-10-20       Impact factor: 47.728

Review 9.  The role of dopamine in bipolar disorder.

Authors:  David A Cousins; Kelly Butts; Allan H Young
Journal:  Bipolar Disord       Date:  2009-12       Impact factor: 6.744

10.  Variation in dopamine genes influences responsivity of the human reward system.

Authors:  Jean-Claude Dreher; Philip Kohn; Bhaskar Kolachana; Daniel R Weinberger; Karen Faith Berman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

View more
  50 in total

Review 1.  TAK-063, a novel PDE10A inhibitor with balanced activation of direct and indirect pathways, provides a unique opportunity for the treatment of schizophrenia.

Authors:  Kazunori Suzuki; Haruhide Kimura
Journal:  CNS Neurosci Ther       Date:  2018-01-09       Impact factor: 5.243

2.  Subcortical modulation of attentional control by second-generation antipsychotics in first-episode psychosis.

Authors:  Toshikazu Ikuta; Delbert G Robinson; Juan A Gallego; Bart D Peters; Patricia Gruner; John Kane; Majnu John; Serge Sevy; Anil K Malhotra; Philip R Szeszko
Journal:  Psychiatry Res       Date:  2013-10-10       Impact factor: 3.222

3.  Aberrant Frontostriatal Connectivity in Negative Symptoms of Schizophrenia.

Authors:  Dinesh K Shukla; Joshua John Chiappelli; Hemalatha Sampath; Peter Kochunov; Stephanie M Hare; Krista Wisner; Laura M Rowland; L Elliot Hong
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

4.  Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons.

Authors:  A Ledonne; A Nobili; E C Latagliata; V Cavallucci; E Guatteo; S Puglisi-Allegra; M D'Amelio; N B Mercuri
Journal:  Mol Psychiatry       Date:  2014-09-30       Impact factor: 15.992

5.  Basal ganglia anatomy and schizophrenia: the role of antipsychotic treatment.

Authors:  E Zampieri; M Bellani; B Crespo-Facorro; P Brambilla
Journal:  Epidemiol Psychiatr Sci       Date:  2014-10-22       Impact factor: 6.892

6.  Extrapyramidal examinations in psychiatry.

Authors:  Richard D Sanders; Paulette Marie Gillig
Journal:  Innov Clin Neurosci       Date:  2012-07

7.  Intrinsic Connectivity of the Globus Pallidus: An Uncharted Marker of Functional Prognosis in People With First-Episode Schizophrenia.

Authors:  Goda Tarcijonas; William Foran; Gretchen L Haas; Beatriz Luna; Deepak K Sarpal
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

8.  Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia.

Authors:  Matthew W Rice; Rosalinda C Roberts; Miguel Melendez-Ferro; Emma Perez-Costas
Journal:  Brain Struct Funct       Date:  2014-10-01       Impact factor: 3.270

9.  Ultrastructural localization of tyrosine hydroxylase in tree shrew nucleus accumbens core and shell.

Authors:  L A McCollum; R C Roberts
Journal:  Neuroscience       Date:  2014-04-24       Impact factor: 3.590

10.  Tissue-specific regulatory circuits reveal variable modular perturbations across complex diseases.

Authors:  Daniel Marbach; David Lamparter; Gerald Quon; Manolis Kellis; Zoltán Kutalik; Sven Bergmann
Journal:  Nat Methods       Date:  2016-03-07       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.